-
69450-3A common method for transformation of DNA plasmids into E. coli is the use of chemically competent cells.
-
69450-4A common method for transformation of DNA plasmids into E. coli is the use of chemically competent cells.
-
CMC0016-40X25UL
Sigma Aldrich
BL21(DE3) ELECTROCOMPETENT CELLS (C15-1302-455)
Price: $1,133.44List Price: $1,259.38The BL21(DE3) Electrocompetent Cells are the first to offer high efficiency cloning and high level protein expression in the same cell. Cloning efficiencies are increased 25-1,000 fold relative to other preparations of BL21 cells, which is -
CMC0016-4X25ULThe BL21(DE3) Electrocompetent Cells are the first to offer high efficiency cloning and high level protein expression in the same cell. Cloning efficiencies are increased 25-1,000 fold relative to other preparations of BL21 cells, which is
-
70235-3
Sigma Aldrich
BL21(DE3) SINGLES COMPETENT CELLS - NOVAGEN (C15-1307-901)
Price: $427.61List Price: $475.12Genotype : F – ompT hsdS B (r B – m B – ) gal dcm (DE3) This product contains genetically modified organisms (GMO). Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the -
70235-4
Sigma Aldrich
BL21(DE3) SINGLES COMPETENT CELLS - NOVAGEN (C15-1307-902)
Price: $698.74List Price: $776.38Genotype : F – ompT hsdS B (r B – m B – ) gal dcm (DE3) This product contains genetically modified organisms (GMO). Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the -
70236-3
Sigma Aldrich
BL21(DE3)PLYSS SINGLES COMPETENT CELLS - NOVAGEN (C15-1307-903)
Price: $427.61List Price: $475.12Genotype: F - ompT hsdS B (r B - m B - ) gal dcm (DE3) pLysS (Cam R ) This product contains genetically modified organisms (GMO). Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the Council -
70236-4
Sigma Aldrich
BL21(DE3)PLYSS SINGLES COMPETENT CELLS - NOVAGEN (C15-1307-904)
Price: $698.74List Price: $776.38Genotype: F - ompT hsdS B (r B - m B - ) gal dcm (DE3) pLysS (Cam R ) This product contains genetically modified organisms (GMO). Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the Council -
M2435-4MGAmino Acid Sequence Glu-Gln-Lys-Leu-Ile-Ser-Glu-Glu-Asp-Leu General description The c-Myc Peptide is a synthetic peptide with an amino acid sequence that corresponds to the amino acids 410-419 of the C-terminal of human c-myc. Application
-
M2435-25MGAmino Acid Sequence Glu-Gln-Lys-Leu-Ile-Ser-Glu-Glu-Asp-Leu General description The c-Myc Peptide is a synthetic peptide with an amino acid sequence that corresponds to the amino acids 410-419 of the C-terminal of human c-myc. Application
-
M2435-1MGAmino Acid Sequence Glu-Gln-Lys-Leu-Ile-Ser-Glu-Glu-Asp-Leu General description The c-Myc Peptide is a synthetic peptide with an amino acid sequence that corresponds to the amino acids 410-419 of the C-terminal of human c-myc. Application
-
J66846-MSynonym(s): Glu-Gln-Lys-Leu-Ile-Ser-Glu-Glu-Asp-Leu Formula: C51H86N12O21 Formula weight: 1203.29 Harmonized Tariff Code: 2924.19